#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pericarditis Chronic cutaneous lupus erythematosus Cutaneous calcification Propionic acidaemia Pustular psoriasis Osteogenesis imperfecta Colitis ulcerative Juvenile psoriatic arthritis Chemical burn Multiple system atrophy Biliary cancer metastatic Ventricular fibrillation Peritoneal neoplasm Cerebellar ataxia Leiomyosarcoma recurrent More trials…

    Learn about Rare Diseases

    Alveolar rhabdomyosarcoma – Basic Information Osteosarcoma metastatic – Basic Information Osteosarcoma – Treatment CADASIL – Life with Disease Combined immunodeficiency – Life with Disease Chronic granulomatous disease – Treatment Amyotrophic lateral sclerosis – Trials in Disease Skin angiosarcoma – Life with Disease Systemic sclerosis pulmonary – Trials in Disease Familial haemophagocytic lymphohistiocytosis – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ursodeoxycholic Acid Clotrimazole Glucose Monohydrate ARGININE GLUTAMATE IMB 101 Lifileucel BIIB115 L-Threonine Florquinitau (18F) Furosemide Mesna HUMAN THROMBIN Pemafibrate Risankizumab Cefepime Hydrochloride Timothy Grass Pollen Extract Entinostat Quinapril Hydrochloride Phenol, Liquefied Finerenone More therapies…

    Learn about Your Condition

    Pulmonary fibrosis Sciatica Chronic sinusitis Lymphocytic leukaemia Immunodeficiency congenital Milk allergy Autoimmune disorder Renal cancer Diabetic retinopathy Ventricular extrasystoles Pulmonary hypertension Alcohol use disorder Tinnitus Partial lipodystrophy Orthostatic hypotension More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Parc Tauli Hospital Universitari

Parc Tauli Hospital Universitari

Parc Del Tauli 1, Sabadell, 08208, Spain

Want to learn more about this study or check if you can participate? Contact us.

  • Study comparing giredestrant plus palbociclib versus letrozole plus palbociclib in patients with estrogen receptor-positive, HER2-negative advanced or metastatic breast cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    Investigated Drugs:
    • Giredestrant
    • Palbociclib
    • Letrozole
    Austria Belgium Denmark France Germany Greece +5

  • Study of Niraparib, Abiraterone Acetate, and Prednisone for Patients with Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Abiraterone
    • Degarelix
    • Relugolix
    Belgium Bulgaria Czechia Denmark France Germany +7

  • Study on Axatilimab for Patients with Idiopathic Pulmonary Fibrosis

    Not recruiting

    2 1
    Investigated Diseases:
    • Idiopathic pulmonary fibrosis
    Investigated Drugs:
    • Axatilimab
    Belgium Czechia France Germany Italy Poland +2

  • Study on the Effects of QUC398 for Patients with Knee Osteoarthritis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Codeine Phosphate Hemihydrate
    • Quc398
    • Paracetamol
    Denmark France Spain

  • Study on Guselkumab for Treating Psoriatic Arthritis in Patients New to Biologic Therapy

    Not recruiting

    3 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Guselkumab
    Bulgaria Czechia Denmark Germany Hungary Italy +5

  • Study on the Safety and Effectiveness of TIN816 for Patients with Sepsis-Related Acute Kidney Injury

    Not recruiting

    2 1
    Investigated Diseases:
    • Acute kidney injury
    • Sepsis
    Investigated Drugs:
    • Tin816
    Austria Belgium Czechia France Germany Hungary +2

  • Study on the Effectiveness of Ianalumab for Treating Moderate to Severe Hidradenitis Suppurativa in Patients

    Not recruiting

    2 1
    Investigated Drugs:
    • Ianalumab
    Austria Belgium France Germany Hungary Spain

  • Study Comparing TAR-200 and Chemotherapy for Patients with High-Risk Non-Muscle-Invasive Bladder Cancer After BCG Treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Bladder cancer
    Investigated Drugs:
    • Mitomycin
    • Gemcitabine Hydrochloride
    Belgium France Germany Italy Poland Romania +1

  • Study of Chemotherapy vs. Nivolumab for Patients with Resectable Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Nivolumab
    Spain

  • Study of Temocillin and Meropenem for Patients with Infections Caused by Resistant Enterobacteriaceae

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Bacterial infection
    Investigated Drugs:
    • Ertapenem Sodium
    • Temocillin Sodium
    • Linezolid
    Spain
Previous Page
1 … 19 20 21 22 23 … 29
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!